Concepedia
Statistics
Publications
10
Citations
463
H-Index
Active since
1994
Affiliations
Washington University in St. Louis(Current)
Alvin J. Siteman Cancer Center
Jewish Hospital
National Cancer Institute
National Institutes of Health
Sherry A. Goodner is an author at Washington University in St. Louis specializing in pharmacology, oncology, and chemotherapy.
Publications per year
1994–2013
A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing
Paula M. Fracasso, Howard A. Burris, Matthew A. Arquette et al. · Clinical Cancer Research · 2007 · 149 citations
Medicine, Oncology, Pharmacology +17
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies
Paula M. Fracasso, Kerry J. Williams, Ronald C. Chen et al. · Cancer Chemotherapy and Pharmacology · 2010 · 70 citations · Full text
Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies
Paula M. Fracasso, Lori J. Goldstein, Dinesh P. de Alwis et al. · Clinical Cancer Research · 2004 · 70 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies
Paula M. Fracasso, Joel Picus, Jonathan D. Wildi et al. · Cancer Chemotherapy and Pharmacology · 2008 · 49 citations
Medicine, Pharmacokinetics, Pharmacology +17
Coaching Intervention As a Strategy for Minority Recruitment to Cancer Clinical Trials
Paula M. Fracasso, Sherry A. Goodner, Allison Creekmore et al. · Journal of Oncology Practice · 2013 · 32 citations · Full text
Medicine, Oncology, Evidence-based Practice +9
1–5 of 10